BioCentury
ARTICLE | Clinical News

DISC HSV herpes simplex virus engineered to disable replication: CNTBY began Phase I safety

July 22, 1996 7:00 AM UTC

Cantab Pharmaceuticals plc (CNTBY), Cambridge, U.K. Product: DISC HSV herpes simplex virus engineered to disable replication, but boost immune response to the virus Indication: Genital herpes (HSV-2) ...